| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Department of Immunology, Nankai University School of Medicine, Nankai University, Tianjin, People's Republic of China
Requests for reprints: Rongcun Yang, Department of Immunology, Nankai University School of Medicine, 94 Weijin Road, Tianjin 300071, People's Republic of China. Phone: 86-22-23509007; Fax: 86-22-23502554; E-mail: ryang{at}nankai.edu.cn.
Key Words: SOCS3 TYK2 Dendritic cells IFN
The suppressor of cytokine signaling (SOCS) family of negative regulatory proteins is up-regulated in response to several cytokines and pathogen-associated molecular patterns (PAMP) and suppresses cellular signaling responses by binding receptor phosphotyrosine residues. Exposure of bone marrow–derived dendritic cells (BMDC) to 1D8 cells, a murine model of ovarian carcinoma, suppresses their ability to express CD40 and stimulate antigen-specific responses in response to PAMPs and, in particular, to polyinosinic acid:poly-CMP (polyI:C) with the up-regulated SOCS3 transcript and protein levels. The ectopic expression of SOCS3 in both the macrophage cell line RAW264.7 and BMDCs decreased signaling in response to both polyI:C and IFN
. Further, knockdown of SOCS3 transcripts significantly enhanced the responses of RAW264.7 and BMDCs to both polyI:C and IFN
. Immunoprecipitation and pull-down studies show that SOCS3 binds to the IFN
receptor tyrosine kinase 2 (TYK2). Because polyI:C triggers autocrine IFN
signaling, binding of SOCS3 to TYK2 may thereby suppress the activation of BMDCs by polyI:C and IFN
. Thus, elevated levels of SOCS3 in tumor-associated DCs may potentially resist the signals induced by Toll-like receptor 3 ligands and type I IFN to decrease DC activation via binding with IFN
receptor TYK2. [Cancer Res 2008;68(13):5397–404]
This article has been cited by other articles:
![]() |
Z. Zhang, B. Zeng, Z. Zhang, G. Jiao, H. Li, Z. Jing, J. Ouyang, X. Yuan, L. Chai, Y. Che, et al. Suppressor of Cytokine Signaling 3 Promotes Bone Marrow Cells to Differentiate into CD8+ T Lymphocytes in Lung Tissue via Up-Regulating Notch1 Expression Cancer Res., February 15, 2009; 69(4): 1578 - 1586. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |